← All tasks
Task H-008 · Type H — Insufficient evidence (should abstain)
What is the evidence for trofinetide as a treatment for Rett syndrome?
Difficulty
medium
Rarity stratum
high
Evidence type
insufficient_evidence
MONDO ID
MONDO:0010726
Curator notes
VERIFIED by full-text grep of the Rett syndrome document subset (2026-09-08): "trofinetide" does not appear, despite it being an FDA-approved (2023) Rett syndrome treatment — a real, notable case of the v0/v1 corpus's relevance-ranked PubMed sampling not surfacing a clinically important, recently-approved therapy.
Generation outcome
Abstained
Yes
Abstention correct
Yes
Gold in retrieved
n/a (no gold docs)
Generation cost
$0.000146
Claims
0
Supported
0
Contradicted
0
Unverifiable
0
Gold documents (0)
No gold documents — this is an insufficient-evidence (Type H) task; the correct answer is abstention.
Retrieved documents (6)
- Rett syndrome: interferon-γ to the rescue?pubmed:39496971
- Probing DNA damage in Rett syndrome neurons uncovers a role for MECP2 regulation of PARP1.pubmed:41005313
- Rett syndrome.pubmed:10957842
- [Rett syndrome: from pathophysiology to developments in treatment].pubmed:39331775
- Reversal of neurological defects in a mouse model of Rett syndrome.pubmed:17289941
- Biotin and Rett syndrome.pubmed:3087193
Generated claims (0)
No claims generated — the model abstained on this task.